Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| BPH procedures · New York | BPH procedures · New Jersey | |
|---|---|---|
| Surgeons, 2024 | 98 | 53 |
| Medicare fee-for-service cases | 8,386 | 6,600 |
| Growth since 2019 (Medicare FFS) | −6.8%/yr | −1.2%/yr |
| Forecast cases (Medicare FFS) | 8,420 in 2030 | 5,800 in 2030 |
| Forecast growth | +0.1%/yr to 2030 | −2.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.6 | 6.3 |
| Medicare Advantage share | 57% | 45% |
| Out of hospital | 43% (−16 pts since 2019) | 53% (−22 pts since 2019) |
| Cases per surgeon | 86 | 125 |
| Top 10 surgeons' share | 43% | 71% |
| Surgeons growing | 14 | 8 |
| New since the base year | 16 | 9 |
| Likely to stop billing it | 23 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $8,147 | $4,868 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.